1. An investigation of the diurnal rhythms of keto-and ketogenic steroid excretion has been carried out in four human subjects. The 6. The significance of these findings is discussed.
INTRODUCTION
A diurnal rhythm in the excretion of urinary ketosteroids was first described by Pincus (1943) . He found minimal excretion by night and maximal values shortly after waking. Numerous reports have confirmed this pattern of adrenocortical excretion and activity with minor differences in the timing and extent of the varia¬ tions (Laidlaw, Jenkins, Reddy & Jacobson, 1954; Di Raimondo, 1955; Doe, Flink & Goodsell, 1954) . Corresponding variations in plasma levels have also been noted (Bayliss, 1955) . Studies on the mechanism of this rhythm have shown it to be unaltered by inactivity, starvation and constant food intake, though reversal has been achieved by the nocturnal administration of adrenocorticotrophic hormone (ACTH) (Laidlaw et al. 1954) . Night work has given conflicting results. The rhythm was unaltered by night work and in blind persons in some cases (Laidlaw et al. 1954; 378 G. W. G. Sharp, S. A. Slorach and H. J. Vipond , although in a later experiment, with strict reversal of the light-darkness activity-sleep schedule, reversal of rhythm occurred (Perkoff, Eik-Nes, Nugent, Fred, Nimer, Rush, Samuels & Tyler, 1959) . No 
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After a further 6 days on this routine, but without the sampling procedure, the subjects reversed back to the day work routine. A further 8-day test phase followed and the adaptation was again noted.
Method of assay of keto-and ketogenic steroids The determinations followed the routine procedure described by Varley (1958) and based on the technique of Norymberski et al. (1953) . Hand shaking was used and 5-15 ml. aliquots of the ethylene dichloride extracts were evaporated to dryness on a boiling water bath. The actual volume taken was roughly proportional to the volume of urine excreted. The whole of the residue was assayed the following day using the Callow-Zimmermann procedure (Varley, 1958) .
In two of the subjects an occasional red or violet extract was obtained in the ketosteroid determination and particularly from the night urine sample. The colours persisted after evaporation and solution in alcohol. In such cases the green and violet absorptions in alcohol were evaluated from a second aliquot and deducted from the corresponding observed extinction values in the assay before applying corrections for general absorption.
RESULTS
The results are expressed as control (period 1), the adaptation to night work (periods 2-5) and the adaptation from night to day work (periods 6-9). In all cases the steroid excretion is expressed as the percentage of the daily output, and is shown in Tables 1 and 2 Fig. 3 where the gradual resumption of the normal excretory patterns may be seen. Detailed excretory patterns are shown in Fig. 2 . From Fig. 3 it can be seen that the night levels approach the control levels more rapidly than the morning levels return to normal. Therefore, adaptation would seem to occur as the peak activity of the adrenal becomes progressively earlier each day after reversal. Heightened adrenal activity moves out of the night period into the middle of the day before finally synchronizing with morning activity. In periods 2, 3, 6 and 7, which represent intermediate reversal phases, a relatively greater excre¬ tion occurred in the middle of the day than during the control period or in periods 5 and 9. As the time for peak adrenocortical activity moved into the early morning again, so the middle of the day excretion decreased (see Fig. 3 ).
DISCUSSION
A diurnal rhythm of keto-and ketogenic steroid output has been observed which is broadly similar to steroid excretory rhythms described by other workers. Quantitative and timing differences are probably due to variations in subjects and experimental conditions. As expected the ketogenic steroid pattern was more variable than that of ketosteroids. In both cases excretion was greater by day than by night. The ketogenic steroid excretion, but not that of ketosteroids, was characterized, by two peaks and a mid-afternoon depression. Other workers have shown patterns with a marked morning peak (Migeon, Tyler, Mahoney, Florentin, Castle, Bliss & Samuels, 1956) or with rising levels from waking to midday with a gradual fall to midnight (Doe, Flink & Goodsell, 1956 ). In the latter work, eight out of twenty-two subjects excreted more 17-hydroxycorticosteroids in the 6 hr. after midday than before. The high evening values reported here were probably due to the camp routine. The subjects had their main meal in the evening and it was associated with an increase of general and mental activity. In addition there was no lessening of the work programme in the evening and subjects worked through until bedtime. That the double peak pattern was not fortuitous was shown by its re-emergence, after adaptation to both time shifts, in periods 5 and 9. It is of interest to note that a lunchtime peak occurs in the diurnal level of circulating eosinophils (Appel, 1938; Rud, 1947; Swanson, Bauer & Ropes, 1952) , the major variations of which are controlled by adrenocortical activity.
The diurnal variation in output of 17-hydroxycorticosteroids has been shown not to be due to variation in the rate of metabolism, or excretion by the kidneys, but is due to increased daytime secretion by the gland (Di Raimondo, 1955 (Browman, 1943) . Certainly light can elicit ACTH secretion in rats (Fortier, 1951) and in human subjects kept in darkness for 3 hr. after waking, the morning eosinopenia and lymphopenia is first lessened and then prolonged beyond the normal minima after emergence. This is strong evidence that light is an important stimulus to ACTH secretion (Sharp, 19606) . In view of the well known resistance to change exhibited by diurnal rhythms, light reception cannot be precluded as an essential stimulus to corti¬ costeroid excretory rhythms.
Reversal of the ketogenic steroid rhythm has been observed after 8 days on a reversed routine. In a similar study (Flink & Doe, 1959 ) the excretion of 17-hydroxy- 24 Endoc. 22, 4
